Anna R Schreiber

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Venues

Cancers

Expert review of anticancer therapy

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, S Lindsey Davis, Christopher H Lieu, Sunnie S Kim, Antonio Jimeno, D Ross Camidge, Jud Williams, Amy M Heim, Anne Martin, John A DeMattei, Nisha Holay, Todd A Triplett, S Gail Eckhardt, Kevin Litwiler, James Winkler, Anthony D Piscopio, Jennifer R Diamond
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers 16 (1) (2023)
Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, S Lindsey Davis, Christopher H Lieu, Sunnie S Kim, Antonio Jimeno, D Ross Camidge, Jud Williams, Amy M Heim, Anne Martin, John A DeMattei, Nisha Holay, Todd A Triplett, S Gail Eckhardt, Kevin Litwiler, James Winkler, Anthony D Piscopio, Jennifer R Diamond
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers 16 (1) (2023)
Anna R Schreiber, Cindy L O'Bryant, Peter Kabos, Jennifer R Diamond
The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecan. Expert review of anticancer therapy (2023)
Anna R Schreiber, Jennifer Santos, Brandon McMahon, Tyler W Buckner, Courtney Olson, Michael O Alberti, Amy Guimarães-Young, Christopher Knoeckel, Lindsey Broussard, Michael Aubrey, Brent E Palmer, Emma Weiss, Geoffrey R Connors, Selene Brunner, Joshua A Wisell, Theresa Pacheco, Dara L Aisner, Jonathan A Gutman
A Case of Fetal-Induced Graft-versus-Host Disease. The New England journal of medicine 389 (7) (2023)
Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, S Lindsey Davis, Christopher H Lieu, Sunnie S Kim, Antonio Jimeno, D Ross Camidge, Jud Williams, Amy M Heim, Anne Martin, John A DeMattei, Nisha Holay, Todd A Triplett, S Gail Eckhardt, Kevin Litwiler, James Winkler, Anthony D Piscopio, Jennifer R Diamond
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers 16 (1) (2023)
Anna R Schreiber, Michelle Andress, Jennifer R Diamond
Tackling metastatic triple-negative breast cancer with sacituzumab govitecan. Expert review of anticancer therapy 21 (12) (2021)

Anna R Schreiber.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anna R Schreiber